A Study to Learn What Participants Think of Treatment With Betamethasone Plus Loratadine to Treat Their Acute Allergic Rhinitis, Also Known as Hay Fever in Mexico

Completed

• Conditions: Rhinitis, Allergic
• Interventions: Other: Online survey

• Registration Number: NCT04645979
• Lead Sponsor: Bayer

Brief Summary

Acute allergic rhinitis is a common allergic reaction to things like pollen or dust. It causes inflammation inside the nose, resulting in symptoms similar to the common cold. Allergic rhinitis is also known as hay fever.

In this study, the researchers want to learn what participants think of betamethasone plus loratadine as a treatment for their acute allergic rhinitis. These participants will have used betamethasone plus loratadine as a treatment for their acute allergic rhinitis within the past two months. During the study, participants will complete an online questionnaire about their experience with betamethasone plus loratadine.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-11-11
• Study First Submitted: 2020-11-23
• Study First Submitted QC: 2020-11-23
• Primary Completion: 2020-11-27
• Study Completion: 2020-11-27
• Study First Posted: 2020-11-27
• Status Verified: 2023-05
• Last Update Submitted: 2023-05-31
• Last Update Posted: 2023-06-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 153

Inclusion Criteria

• Participants who used betamethasone plus loratadine within the previous 2 months for the treatment of acute episodes of allergic rhinitis
• Participants allowing to use the data for research and marketing purposes as well as talking to authorities
• Participants allowing us to use the pseudo-randomized individual data for further data analysis
• Able to read and understand the language of the online questionnaire

Exclusion Criteria

• None

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Participants	Online survey	Participants who used betamethasone plus loratadine to treat allergic rhinitis within the previous two months.

Primary Outcome Measures

Name	Time	Method
Experience with betamethasone plus loratadine via an online questionnaire	2 months	Participants' experiences with betamethasone plus loratadine used under real life conditions.

Trial Locations

Locations (1)

Many locations; 🇲🇽 Multiple Locations, Mexico